Actionable insights straight to your inbox

logo_equities.svg

Francis Gaskins

Juno Therapeutics (JUNO) JUNO is building a fully-integrated biopharmaceutical company focused on revolutionizing medicine by re-engaging the body’s immune system to treat cancer. It is
Medovex (MDVXU) intends to build a portfolio of medical device products in areas where its world-class management team believes the largest, most targetable market opportunities exist.  It is
Bellicum Pharmaceuticals (BLCM) is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including both